Bruker Corporation

    Jurisdiction
    United States
    LEI
    LEBZ6VLQ6I8XB1NHVY15
    ISIN
    US1167941087 (BRKR)
    Sectors
    1. Healthcare
    2. Medical - Equipment & Services

    Scores

    InsiderPie Expert Score
    53 / 100
    Better than peer group:
    50 / 100
    Fair value (Benjamin Graham formula)
    €40.74 32.1% undervalued
    Financial strength (Piotroski F-Value)
    5 / 9
    Fundamental strength relative to industry (Mohanram G-Value)
    5 / 7

    Profile

    Bruker Corporation is a global developer, manufacturer, and distributor of high-performance scientific instruments and analytical and diagnostic solutions. Read full profile

    Stock price

    Stock price loading... No stock price available Stock price provided by Lang & Schwarz Steigende Zinsen und niedrigere Bewertungen für Wachstumsaktien im Allgemeinen Eine Gewinnwarnung beim Konkurrenten Adyen signalisiert eine Abkühlung des europäischen Markts für Zahlungsdienstleistungen. Eine Gewinnwarnung von Wordline SA triggert einen massiven Kursverlust.

    Configure chart

    Adjust colors to be more accessible for red-green-colorblind users.
    Scale
    Moving average Display a moving average line on the chart.

    Fundamentals

    Net revenue
    €2.94B
    Gross margin
    48.0%
    EBIT
    €156.86M
    EBIT margin
    5.3%
    Net income
    €67.89M
    Net margin
    2.3%

    Statement period: - (published )

    Estimates

    Fiscal Year Net revenue Net income
    €2.98B +1.4% €299.93M +341.8%
    €3.13B +4.9% €334.31M +11.5%
    €3.30B +5.5% €366.89M +9.7%

    Dividends

    Last dividend amount
    $0.05
    Ex date
    Payment date
    Dividend payout ratio
    38.2%

    Earnings Calls

    Latest earnings call: May 2, 2024

    Investor transactions

    Name Shares Value Last change Change type
    Peter Brown 284K $11.84M +218K Buy

    Add to watchlist

    Notifications